Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.

Explorateur d’archives

Parcourir et rechercher des captures

Note importante

Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.

Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.

Parcourir les sites archivés

Parcourir toutes les sources →

Consultation Notice: Health Canada Requests Feedback on Potential Impacts and Uses if Company Names were added to the Generic Submissions Under Review List January 7, 2019 Our file number: 18-121970-181 As a regulator, Health Canada plays an important role in protecting the…

Consultation on Draft Guidance Document: Regulatory Requirements for Drug Identification Numbers (DINS) Current status: Closed Opened on January 25, 2019 and will close to new input on February 25, 2019. The purpose of this consultation is to seek feedback from stakeholders on…

Notice: Discontinuation of Acknowledgement Letters for Regulatory Activities received by Health Canada January 30, 2019 Our file number: 19-101387-751 In an effort to modernize and align internal processes, Health Canada is proposing to discontinue the issuance of letters of…

Scientific Advisory Committee On Respiratory and Allergy Therapies (SAC-RAT) Record of Proceedings – November 2, 2018 Committee members present: Irvin Mayers (Chair), Donald Cockcroft, Eugenia Palylyk- Colwell, Sharon Dell, Myrna Dolovich, Murray Ducharme, Alan Kaplan, Larry…

Questions and Answers: Prescription Opioids – Sticker and Handout Requirements for Pharmacists and Practitioners Date: 2019/02/07 PDF version Document change log Date Change Location (section, paragraph) Nature of and/or reason for change 2018/05/02 Initial issuance of guidance…

Notice to Stakeholders: Updates to the Opioid Patient Information Handout Date: March 15, 2019 Our reference number: 19-105242-212 The purpose of this Notice is to notify stakeholders that Health Canada has made changes to the opioid patient information handout entitled “ Opioid…

What we heard: A summary of scanning and consultations on what’s next for health product regulation Download the alternative format (PDF format, 575 KB, 9 pages) Organization: Health Canada Type: Report Date published: March 2019 1.0 Introduction and Context Scientific and…

Drug Products - Canada.ca

Health CanadaCaptures 24Dernière capture 11 avr. 2026en

Drug Products Current Consultations 2026 Consultation: Canadian Access, Watch, Reserve classification of antimicrobial drugs for human use [2026-04-09 – 2026-06-08] Consultation: Removing zuranolone from the Prescription Drug List [2026-02-07 – 2026-04-18] Consultation: Release…

Page 4268 sur 6399Affichage de 42671 à 42680 sur 63986

Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.